Skip to content

Clinical trials

Phase 2 Diabetes Mellitus, Type 2 trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Phase: Phase 2 Country / region: Russia Clear all

41 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20063
200711
20084
20097
20103
20113
20121
20151
20161
20172
20213

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed37
Terminated3
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim6
Hoffmann-La Roche6
Eli Lilly and Company5
GlaxoSmithKline3
AstraZeneca2
Ionis Pharmaceuticals, Inc.2
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.2
Novo Nordisk A/S2
Sanofi2
ActivX Biosciences, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 241
Diabetes Mellitus9
Renal Insufficiency, Chronic2
Body Weight1
Diabetes Mellitus, Lipoatrophic1
Diabetic Nephropathies1
Dyslipidemias1
Endocrine System Diseases1
Glucose Metabolism Disorders1
Heart Failure1

Trials

Showing 1 to 25 of 41. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.